Ignite Creation Date:
2024-05-06 @ 2:18 PM
Last Modification Date:
2024-10-26 @ 1:28 PM
Study NCT ID:
NCT04278222
Status:
RECRUITING
Last Update Posted:
2024-07-10
First Post:
2020-02-19
Brief Title:
Anlotinib Plus Toripalimab as First-line Treatment for Advanced Gastric Cancer With ECOG 2 APICAL-GC
Sponsor:
Shanghai Changzheng Hospital
Organization:
Shanghai Changzheng Hospital
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Toripalimab |
| Gastric Cancer |
| Immunotherapy |
| Anlotinib |
| Toripalimab |
Keywords: